Tuesday, November 5, 2024
HomeTagsIOnctura

iOnctura

iOnctura to Share Clinical and Preclinical Data on IOA-244 and IOA-289 at ESMO-IO in December

iOnctura SA, a clinical stage oncology company targeting core resistance and relapse mechanisms at the tumor-stroma-immune interface, announces it will present clinical and preclinical...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics